510(k) K100336
K100336 is an FDA 510(k) premarket notification submitted by Eragen Biosciences for the device "MULTICODE - RTX HERPES SIMPLEX VIRUS 1 AND 2 KIT, MODEL 3711". The FDA issued a decision of Substantially Equivalent on May 12, 2010. The device falls under product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay), a Class II device regulated under 21 CFR 866.3305. Eragen Biosciences has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 12, 2010
- Date Received
- February 5, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Herpes Simplex Virus Nucleic Acid Amplification Assay
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type
A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.